IN THE NEWS
August 14, 2018:
Avenue Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights
August 13, 2018:
Mustang Bio Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights
Mustang Bio and St. Jude Children’s Research Hospital Enter into Exclusive Worldwide License Agreement for a Ground-Breaking, Clinical-Stage Lentiviral Gene Therapy with Curative Potential for X-linked Severe Combined Immunodeficiency
Checkpoint Therapeutics Announces Clinical Data on EGFR Inhibitor CK-101 Selected for Late-Breaking Oral Presentation at IASLC 19th World Conference on Lung Cancer
QUICK LINKS
PIPELINE
